CELL SIGNALING TECHNOLOGY search Cell Signaling Technology ABL1 products
includes other brands or spellings
|
| wb | | Cell Signaling Technology antibody against phospho-c-Abl (Tyr-245) was used in western blot to identify a member of forkhead transcription factor FKHRL1 as a downstream effector of STI571-induced cell cycle arrest in BCR-ABL-expressing cells. |
SANTA CRUZ BIOTECHNOLOGY search Santa Cruz Biotechnology ABL1 products
includes other brands or spellings
|
| block, ip | | Santa Cruz Biotechnology a rabbit polyclonal antibody against Abl K12 was used in immunoprecipitation and kinase assays to study the interaction of VASP with Abl. |
| ic, ip, wb | | Santa Cruz Biotechnology polyclonal anti-c-Abl (K12) antibody was used in western blot, immunoprecipitation, and immunocytochemistry to study the interaction of Dok-R and c-Abl. |
| ip, wb | | Santa Cruz Biotechnology rabbit polyclonal anti-c-Abl (K-12) antibody was used in immunoprecipitation and western blot to study p73 nuclear matrix association regulation. |
| ip, wb | | Santa Cruz Biotechnology anti-c-Abl (K-12) antibody was used in western blot and immunoprecipitation to study catalase activity reegulation during oxidative stress response. |
| ip, wb | | Santa Cruz Biotechnology anti-c-Abl antibody was used in western blot and immunoprecipitation to detect c-Abl in NCI-H1299 cells. |
| ip, wb | | Santa Cruz Biotechnology monoclonal anti-c-Abl antibody was used in human foreskin fibroblasts (A1-F) and in immunoprecipitation, western blot to study the roles for TGF-beta1 and cell adhesion in regulating HEF1 expression and phosphorylation. |
| ip | | Santa Cruz Biotechnology anti-abl antibody was used in immunoprecipitation to characterize Lyp in the Bcr-Abl signal transduction pathway. |
| wb | | Santa Cruz Biotechnology mouse monoclonal anti-c-Abl antibody was used in western blot to detect c-Abl in K562-R, LAMA-R and their parent cells treated with 1 µM imatinib mesylate. |
| wb | | Santa Cruz Biotechnology Inc c-Abl antibody was used in western blot to study apoptotic induction by apicidin in human Bcr-Abl-positive leukemia cells. |
| wb | | Santa Cruz Biotechnology anti-Abl antibody was used in western blot to study activation of protein kinase D. |
| wb | | Santa Cruz Biotechnology mouse monoclonal c-Abl antibody (24–11) was used in western blot to study the interactions between pharmacological MEK1/2 inhibitors and STI571 in Bcr/Abl-positive human leukemia cells. |
BD BIOSCIENCES search BD Biosciences ABL1 products
includes other brands or spellings
|
| ip | | BD Biosciences Pharmingen anti-Abl antibody was used in immunoprecipitation to study Bcr-Abl-mediated apoptosis protection. |
| wb | | Pharmingen ABL antibody was tested in western blot by Abminer. |
| wb | | BD PharMingen anti-Abl antibody was used in western blot to study that association of Bcr-Abl with the proto-oncogene Vav is implicated in activation of the Rac-1 pathway. |
| wb | | Pharmingen monoclonal anti-ABL antibody was used in western blot to study the evidence for a positive role of SHIP in the BCR-ABL-–mediated transformation of primitive murine hematopoietic cells and in human chronic myeloid leukemia. |
| wb | | Pharmingen mouse monoclonal anti-c-Abl antibody was used in human 293T cells and in western blot to study the effect of RET/PTC3 on the Erk8 mitogen-activated protein (MAP) kinase. |
| wb | | Transduction Laboratories a monoclonal antibody against Abl 8E9 was used in western blot to study the interaction of VASP with Abl. |
MILLIPORE search Millipore ABL1 products
includes other brands or spellings
|
| ip, wb | | Upstate Biotechnology c-Abl antibody was used in western blot and immunoprecipitation to demonstrate MGO enhancing cisplatin-induced apoptosis by activating PKC-delta. |
THERMO FISHER SCIENTIFIC search Thermo Fisher Scientific ABL1 products
includes other brands or spellings
|
| ih | | Lab Vision/NeoMarkers ABL1 antibody was tested in immunohistochemistry by HPA (CAB002686) . |
| wb | | Lab Vision c-Abl (Ab-1) antibody was tested in western blot by Abminer. |
CN BIOSCIENCES
|
| wb | | CN Biosciences anti-Abl antibody was used in western blot to detect Abl in U937, Jurkat, and K562 cell lysates. |
Articles Reviewed |
| 1. Jonathan P Godbout et al. Methylglyoxal enhances cisplatin-induced cytotoxicity by activating protein kinase Cdelta. 2002 |
| 2. Zaruhi Poghosyan et al. Phosphorylation-dependent interactions between ADAM15 cytoplasmic domain and Src family protein-tyrosine kinases. 2002 |
| 3. Chunrong Yu et al. Pharmacologic mitogen-activated protein/extracellular signal-regulated kinase kinase/mitogen-activated protein kinase inhibitors interact synergistically with STI571 to induce apoptosis in Bcr/Abl-expressing human leukemia cells. 2002 |
| 4. Florian Bassermann et al. Association of Bcr-Abl with the proto-oncogene Vav is implicated in activation of the Rac-1 pathway. 2002 |
| 5. Alan K Howe et al. Regulation of vasodilator-stimulated phosphoprotein phosphorylation and interaction with Abl by protein kinase A and cell adhesion. 2002 |
| 6. Mingzhe Zheng et al. Regulation of HEF1 expression and phosphorylation by TGF-beta 1 and cell adhesion. 2002 |
| 7. Norio Komatsu et al. A member of Forkhead transcription factor FKHRL1 is a downstream effector of STI571-induced cell cycle arrest in BCR-ABL-expressing cells. 2003 |
| 8. Peter Storz et al. Tyrosine phosphorylation of protein kinase D in the pleckstrin homology domain leads to activation. 2003 |
| 9. Wenwen Chien et al. Characterization of a myeloid tyrosine phosphatase, Lyp, and its role in the Bcr-Abl signal transduction pathway. 2003 |
| 10. Zubin Master et al. Dok-R binds c-Abl and regulates Abl kinase activity and mediates cytoskeletal reorganization. 2003 |
| 11. Cheng Cao et al. Catalase activity is regulated by c-Abl and Arg in the oxidative stress response. 2003 |
| 12. Merav Ben-Yehoyada et al. c-Abl tyrosine kinase selectively regulates p73 nuclear matrix association. 2003 |
| 13. Xiaoyan Jiang et al. Evidence for a positive role of SHIP in the BCR-ABL-mediated transformation of primitive murine hematopoietic cells and in human chronic myeloid leukemia. 2003 |
| 14. June-Won Cheong et al. Induction of apoptosis by apicidin, a histone deacetylase inhibitor, via the activation of mitochondria-dependent caspase cascades in human Bcr-Abl-positive leukemia cells. 2003 |
| 15. Yun Dai et al. A Bcr/Abl-independent, Lyn-dependent form of imatinib mesylate (STI-571) resistance is associated with altered expression of Bcl-2. 2004 |
| 16. Paula B Deming et al. Bcr-Abl-mediated protection from apoptosis downstream of mitochondrial cytochrome c release. 2004 |
| 17. Soon-Young Choi et al. Activation of Bak and Bax through c-abl-protein kinase Cdelta-p38 MAPK signaling in response to ionizing radiation in human non-small cell lung cancer cells. 2006 |
| 18. Carlo Iavarone et al. Activation of the Erk8 mitogen-activated protein (MAP) kinase by RET/PTC3, a constitutively active form of the RET proto-oncogene. 2006 |
| 19. Sylvia M Major et al. AbMiner: a bioinformatic resource on available monoclonal antibodies and corresponding gene identifiers for genomic, proteomic, and immunologic studies. 2006 |
| 20. Anja Persson et al. A human protein atlas based on antibody proteomics. 2006 |